Trial Profile
A Retrospective Study Assessing the Effectiveness of Botox (Onabotulinum Toxin Type A ) in the Management of Multiple Types of Chronic Non-Migraine Headaches
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache; Post-traumatic headache
- Focus Therapeutic Use
- 11 May 2018 New trial record
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology.